pcna 2010 impact report

PCNAPreventive CardiovascularNurses Association

2010

RepoRtimpact

At least 80% of premature deaths from heart disease and stroke could be avoided if risk factors such as tobacco use, unhealthy diet, and physical inactivity are controlled. Nurses and advanced practice nurses play a key role in identifying and implementing cardiovascular risk factor reduction strategies for their patients. They are educators, researchers and clinicians working to improve cardiovascular health worldwide.

The Preventive Cardiovascular Nurses Association supports these efforts each year by providing our network of over 25,000 health care professionals with professional education, clinical tools and patient education. We believe in strong partnerships and continue to partner with like-minded organizations to address advocacy issues and educate policy makers. Perhaps one of the most impactful initiatives we tackled this year was our joint effort with the Partnership for Prevention to host two caucuses in Washington D.C. focusing on reducing salt in processed foods and exploring ways to stop childhood obesity. Over one hundred legislative representatives attended the caucuses and met with our organizations to discuss bills that address these global concerns.

This impact report highlights efforts like this one and the total impact our organization and members have had on cardiovascular disease awareness and prevention this year. We are proud of the accomplishments our entire organization has made and look forward to many successful years ahead.

Jerilyn K. Allen, RN, ScD, FPCNA, FAAN President, 2010 PCNA Board of Directors

Sue Koob, MPA ChiefExecutiveOfficer

oveRviewreport

2

100%

t he current state of health care demands that nurses play a leading role in identifying and implementing cardiovascular risk reduction strategies. PCNA

is committed to the continued education and support of nurses so they may successfully rise to this challenge.

This 2010 impact report details mission-related accomplishments in six core goal areas. These initiatives support our overall mission to promote nurses as leaders in cardiovascular risk reduction and disease management.

CoRe GoALSDisseminate information oninnovativeandfiscally responsible models of cardiovascular care delivery

promote individual and community education in cardiovascular risk reduction and disease management across the lifespan

promote professional certification and development for nurses specializing in cardiovascular disease prevention and management

increase public and political awareness of the critical role nurses play in comprehensive cardiovascular risk reduction

promote the utilization and dissemination of research and to support evidence-based practice in cardiovascular risk reduction and disease management

Foster productive liaisons with professional organizations that share similar goals

of PCNA Annual Symposium attendees believe that to provide the best care for their patients, they must engage in continuous learning. PCNA provides live and online

educational opportunities to over 25,000 health care providers each year.


3

57%hoSpitAL

inpAtient: 52% outpAtient: 48%

17%otheR

2%RehAb CLiniC

1%pubLiC heALth

7%univeRSity

16%phySiCiAn pRACtiCe

pRACtiCe SettinGS

61%Rn

23%np

6%otheR

4%CnS

6%unknown

pRoFeSSionAL DeSiGnAtion

who ARe ouR MeMbeRS?• Approximately 3,000

active members.

• They work in hospitals, clinics and universities.

• Members treat hypertension, heart failure, diabetes, obesity, dyslipidemia and other CVD risk factors including lifestyle.

• Members see over 2 million patients per year.

• Most members spend 45 minutes on initial patient visits and 20-30 minutes on follow-up visits.

• PCNA continues to demonstrate that nurse case managed patients have better success in reaching their CVD goals.

DeMoGRAphiCSmembership

67%21+ yeARS

10%0-5 yeARS

6%6-10 yeARS

6%11-15 yeARS

11%16-20 yeARS

expeRienCe in nuRSinG

4

ChAnneLSmedia

PCNA has fostered a large community of health care professionals through a strategic communication strategy that keeps members and other health care professionals informed about educational opportunities, clinical tools and news about cardiovascular disease prevention.

PCNA uses the following media channels to disseminate information about cardiovascular disease prevention and risk reduction to health care professionals and communities worldwide.

pCnA.netThe PCNA website is the main portal for all live and online continuing education courses, membership, and the latest news about cardiovascular disease prevention. In 2010, pcna.net received over 89,000 visits and nearly 500,000 pageviews.

pCnA enewSPCNA eNews electronic newsletter is sent monthly to over 25,000 health care professionals. The newsletter covers topics about live and online continuing education events, PCNA programs, membership information, important topics and events about cardiovascular disease, and news from supporters and liaison organizations.

Sponsorship opportunities are available to companies and organizations interested in reaching our database with their news and information.

the JouRnAL oF CARDiovASCuLAR nuRSinGTheJournalofCardiovascularNursing(JCN)istheofficialjournalofPCNA. Devoted to cardiovascular nursing practice and research, this journal is published bi-monthly with a circulation of nearly 5,000 and includes state-of-the-art practice articles. All active PCNA members receiveacopyaspartoftheirmembershipbenefits.

Each issue has a section on prevention and includes pages devoted to PCNA membership information, Annual Symposium news, news about collaborations, and products and services offered by PCNA.

JCN’s 2010 Impact Factor is 1.444, ranked 14/70 in Nursing and 71/95 in Cardiac & Cardiovascular Systems.

pReSSPCNA distributes press releases to keep members, our network of health care professionals, partners, corporate contacts and the media informed of news about cardiovascular disease prevention and PCNA.

DiSSeMinAte inFoRMAtion

5

A primary mission of PCNA is to provide members with professional resources not found anywhere else.

Thematerialsdistributedaredesignedtoincreasescientificknowledgeofnationalguidelines,support clinical application of cardiovascular risk reduction strategies, and offer quick-reference guides for easy access to key information on risk factors. PCNA distributed over 20,000 clinical tools to health care professionals this year.

poCket GuiDe: nAtionAL GuiDeLineS & tooLS FoR CARDiovASCuLAR RiSk ReDuCtionWith an updated version released in 2009, this is a “must have” resource for all health care professionals involved in cardiovascular risk reduction. Thispocketguideisthefirst-evercompilationofnationalguidelinetables,algorithms,andresourceshighlightingscientificandclinicalaspectsofprimary and secondary CVD risk reduction.

pCnA FoRMS onLinePCNA offers free downloadable clinical forms and patient handouts for health care professionals to integrate into patient medical records.

LAMinAteD CARD SeRieSThese member-only quick-reference cards provide a step-by-step approach to patient evaluation and treatment. Over 30,00 cards have been distributed to health care professionals.

•CholesterolGuidelines

•ElevatedTriglycerides&LowHDL

•NEWin2010!AntiplateletTherapy

tooLSclinical

200,000health care providers received our educational products & public health awareness campaigns to date.

over


Elevated Triglycerides & Low HDLA Quick Look at Patient Evaluationwww.pcna.net

Triglycerides (TG) and HDL Screening

In adults over the age of 20 years, a fasting lipid profile should be obtained every 5 years including: total cholesterol,LDL-cholesterol, HDL-cholesterol, and triglycerides. Only total cholesterol and HDL-cholesterol are accurate in a non-fasting state. Patients need to be advised to fast for 10-12 hours prior to having their fasting panel drawn for an accurate measurement of triglycerides.

Step 1: Identify Common Causes

Common Causes of Elevated TG:• Overweight/Obesity• Physical Inactivity• Cigarette Smoking• Excess Alcohol Intake• Very High Carbohydrate Diet (> 60% of total energy)• Diseases:

Type 2 Diabetes, Chronic Renal Failure, Nephrotic Syndrome• Certain Drugs:

Corticosteroids, Protease Inhibitors for HIV, Beta-Adrenergic Blocking Agents, Estrogens

• Genetic Factors

Common Causes of Low HDL:• Elevated TG• Overweight/Obesity• Physical Inactivity• Cigarette Smoking• Very High Carbohydrate Diet (> 60% of total energy)• Type 2 Diabetes• Certain Drugs:

Beta Blockers, Anabolic Steroids, Progestational Agents• Genetic Factors

Step 2: Perform Clinical Assessment

• Height, Weight, BMI, Waist Circumference• Fasting Lipid Panel• CV Exam• Lifestyle: Physical Activity, Diet, Alcohol, Smoking• Acanthosis Nigricans• Past Medical History: Pancreatitis, Renal Disease,

Liver Disease, Vascular Disease, Diabetes,Thyroid Disease, Cushings Syndrome, HIV, PCOS

• Family History of CVD and Lipid Disorders• Medications (Prescription & OTC)

For Very High TG (≥ 500 mg/dL):• Abdominal Pain/Tenderness to Palpation• Hepatomegaly, Splenomegaly• Cutaneous Flushing, Dry Skin, Pruritis, Xanthomas

Step 3: Assess for Metabolic Syndrome

Diagnosis = Any 3 of the Following Criteria:• Waist Circumference ≥ 40” in Men

≥ 35” in Women• TG ≥ 150 mg/dL• HDL < 40 mg/dL in Men

< 50 mg/dL in Women• BP ≥ 130/85 mm Hg• Fasting Glucose ≥ 100 mg/dL

LDL goal is first-line treatment. Non-HDL is the secondary target of therapy when TG ≥ 200 mg/dL.Non-HDL Goals Elevated triglycerides of ≥ 200 mg/dL are secondary target of therapy.

Non-HDL-C: • Represents: triglyceride-rich lipoproteins — considered atherogenic• Sum of LDL & VLDL cholesterol is a target of cholesterol lowering therapy• Total cholesterol minus HDL = non-HDL-cholesterol

ATP III Guidelines

Triglycerides (mg/dL)Less than 150 Normal150–199 Borderline High200–499 HighGreater than or equal to 500 Very High

HDL (mg/dL)Less than 40 Low (Men)Less than 50 Low (Women)Greater than or equal to 60 Optimal

� When lab is drawn to test TG, fasting 10–12 hours is required.

Non-HDL-C goal is 30 mg/dL higher than the LDL target

Data adapted from ATP III Final Report. Circulation. 2002ATP III 2004 and 2005 Updates

Or on Drug Rx

Dual Antiplatelet Therapy in Post Acute Coronary Syndrome

Tips for Nursing Practice

Copyright ©2010 Preventive Cardiovascular Nurses Association

Platelets

Section 3: To Reduce GI Bleeding

Section 1: The Role of Platelets in Thrombotic Events

Dysfunctional or damaged endothelial cells release growth factors, cytokines, monocytes and

macrophages, T-lymphocytes, and platelets

Creates an inflammatory and proliferative environment

Collagen and von Willebrand factor in the presence of inflammation cause damaged endothelium to become

the site of platelet aggregation and adhesion

Platelet intracellular signaling molecules are released, including thromboxane A2, serotonin, epinephrine, and adenosine diphosphate (ADP)

Enhanced platelet activation and adhesion

Thrombin, fibrin, interaction between ADP and platelet receptors, and release of

von Willebrand factor from activated platelet

Thrombus Formation

Section 2: Site of Actions of Antithrombotic Agents

Collagen Leukocytes

Platelets

Thromboxane A2

Activated Platelets

Fibrinogen Cross-Linking

Platelet Aggregation

Fibrinogen Fibrin ThrombusPlasmin

Fibrin Degradation

vWF ADP

Aspirin Clopidogrel Prasugrel

Thrombolytics

Test for H. pylori and treat if infected

PPI*

PPI

More Than One Risk Factor:Age 60 Years or More

Corticosteroid Use Dyspepsia or GERD** Symptoms

Dual Antiplatelet Therapy: ASA and ThienopyridinesPharmacologic treatment for patients post Acute Coronary Syndrome (ACS) has evolved to include potent antiplatelet therapy. Because of the complex interactions between platelet aggregation factors, combination therapy using ASA and thienopyridines is currently considered the standard of care. As a result of this progress in treatment, nursing management of patients post ACS has also evolved.

Adapted From Selwyn AP. Am J Cardiol, 2003

YES YES

NO

Low Molecular Weight Heparin

(LMWH)

*Proton Pump Inhibitor**Gastroesophageal Reflux Disease

Reproduced with permission Circulation. 2008;118:1894-1909. ©2008 American Heart Association, Inc.

History of Ulcer Complication

History of Ulcer Disease (non-bleeding)

GI Bleeding

Dual Antiplatelet Therapy

Concomitant Anticoagulant Therapy

GP IIb/Illa Inhibitors

6

PCNA is proud to produce high quality resources to support patients as they deal with modifying CVD risk factors through education and lifestyle changes. PCNA collaborates with many partners to bring these tools to health care providers and patients.

Get touGh on AnGinA hAnDbook AnD bRoChuReSA newly revised 30-page educational handbook helps patients suffering with this chronic condition. In plain language, it covers information about angina and what to do if it changes, angina triggers, working with family members and health care professionals,andspecifictestsandtreatments.Over50,000 handbooks and 1 million patient brochures have been distributed to date.

DiAbeteS-CARDiovASCuLAR DiSeASe tooL kit: CD-RoMThe result of a collaboration between the American Diabetes Association, American College of Cardiology and PCNA, this tool kit focuses on increasing patient awareness of diabetes and CVD risk and has reached over 5 million patients.

bLooD pReSSuRe: how Do you MeASuRe up?Developed by PCNA to educate patients at risk for CVD due to hypertension. The booklet provides information on home blood pressure monitoring, exercise and nutrition, behavior change and medication therapies. PCNA has distributed over 200,000 booklets to patients to date.

teAR pAD SeRieS:These easy 1-page information sheets have reached over 300,000 patients in clinical settings nationwide.

•TriglyceridesandHDL:WhatYouNeedtoKnow

•NEW!AntiplateletTherapy:WhatYouNeedtoKnow

1

Your Guide to Understanding andTaking Control of Your Angina

AnginaTough

Geton

An Educational Booklet for Patients and Families

Your Guide to Understanding and

Taking Control of Your Angina

AnginaTough

Geton

An Educational Booklet for Patients and Families

Check your blood pressure numbers.

Eat a healthy diet.

Learn about your medicines.

How do youmeasure up?

Blood Pressure

Exercise.

pRoMote inDiviDuAL AnD CoMMunity eDuCAtion

MAteRiALSpatient

High Triglycerides Increase Your Risk for Heart Disease

Low HDL Cholesterol Levels Increase Your Risk for Heart Disease

Lifestyle Factors of High Triglycerides and Low HDL

• Overweight /obesity • Smoking cigarettes (lowers HDL)• Sedentary/ inactive lifestyle • Family history (genetics) may also play• Diet high in refined carbohydrates a role in high triglycerides/low HDL• Poorly controlled diabetes (high blood sugar)

What are Triglyceridesand HDL?

Triglycerides (TG) are fats found in the blood. They are affected by weight, lifestyle, diet, and family history.

Lower is better.

HDL is called the “good cholesterol” because high levels of HDL can help protect against heart disease.

Higher is better.

Why are they important?

High triglycerides and low HDLincrease your risk for heart disease.

This worksheet shows you how to reduce your risk by loweringtriglycerides and raising HDL.

WHAT YOU NEED TO KNOW

Triglycerides and HDL

Triglycerides (mg/dL) Level of Risk

Less than 150 Normal150–199 Borderline High200–499 High500 or greater Very High

My Numbers

TG ___________

HDL __________

When blood is drawn to test TG, fasting is required (water and medications only) for 10–12 hours prior to the appointment.

HDL (mg/dL) Risk Level

Less than 40 is considered low in men High RiskLess than 50 is considered low in women High Risk60 or greater is optimal for both men and women Low Risk

NOTE: Some medications may affect TG and HDL. Be sure your healthcare provider is aware of all medications and dietary supplements you take.

Choose High Fiber CarbohydratesAvoid refined grains such as white bread, whiterice and pasta, which can raise triglycerides morethan whole grain and high fiber products.

• Choose whole wheat products and include oat bran for fiber

Limit Simple Sugars• Limit simple sugar intake

to 1–2 servings/week• 1 serving = 100 calories

Simple Sugars include:• Corn syrup, honey• Sweetened soft drinks• Candy / baked goods• Jam / jelly

Eat Fruits and Vegetables• 4–6 or more serving of fruits

and vegetables/day• Better choices are fresh or frozen

with “no added sugars”• 100% fruit juices (Limit 1/2 cup/day)

Serving size:1 medium apple = 1 serving 1/2 cup steamed vegetables = 1 serving1 cup raw vegetables = 1 serving

How to Lower Your TriglyceridesNutrition

Choose “Good” FatsUse monounsaturated fats—canola, olive or peanut oil. Examples of one serving:

• 1 tsp oil• 1 TBS walnuts, almonds, peanuts• 1 TBS reduced fat peanut butter

or 2 tsp regular peanut butter

Avoid:• Saturated Fats—coconut oil, palm oil,

hydrogenated fats, animal fats• Trans Fats—used in baked goods

and some margarines

Add:• Omega 3 Fatty Acids

Eat 2–3 servings per week of “cold water” fish—salmon, albacore tuna, mackerel;one serving = 3 ounces after cooking

• Ground flax seed, flax seed oil, nuts and fish oil capsules

�

�Data adapted from ATP III Final Report. Circulation. 2002

Data adapted from ATP III Final Report. Circulation. 2002

Product ID 00002000710 Copyright ©2010 Preventive Cardiovascular Nurses Association

WHAT YOU NEED TO KNOW

Antiplatelet TherapyWhy are you taking antiplatelet medicines?Antiplatelet medicines stop blood clots from forming. This helps to prevent a heart attack or stroke. If you have had a heart attack, stroke, or stents placed in your heart arteries, you probably have been asked to take antiplatelet medicines. These medicines will lower your chance of having a heart attack or stroke.

No blood flow in a heart artery results in a heart attack. If this happens in an artery going to the brain, a stroke occurs.A partially blocked artery can become completely blocked by a blood clot.

Coronary Arteries

Platelets Clumping

Flow of Platelets in a Normal Artery

Flow of Platelets in a Blocked Artery

Heart

Blockage (clot) in the Artery

Often used antiplatelet medicines: • Aspirin and Plavix® (clopidogrel) or Effient® (prasugrel)If prescribed more than one, it is important to take both drugs as they work in different ways to stop blood clots from forming. These medicines are often used by people who have had a heart attack, stroke, or stents placed in the heart.

How to Take Your Antiplatelet MedicinesAlways Take Your Medicines Exactly As You Were Told

Platelets are cells in the blood that help us make blood clots. This is a normal body function. If you have heart disease risk factors (such as smoking, high blood cholesterol, high blood pressure, or diabetes) your platelets can clump together more easily and can form a more serious blood clot. Blood clots can be a problem especially if they are in your heart, brain, or other arteries in your body. Antiplatelet medicines help to prevent these blood clots.

Name Dosage When to Take

Instructions For Taking Your Antiplatelet Medicines

You can reach your doctor or nurse at: ________________

1. Always talk to your heart doctor or nurse before stopping or changing the way you take your antiplatelet medicines.

2. If you forget a dose you can take it later that day. If you missed taking it entirely, do not catch up by taking two doses the next day.

3. Ask your doctor or nurse how long you will be taking these medicines. You may be on two antiplatelet medicines for a year or more and may stay on aspirin for a long time.

4. Tell ALL of your doctors and nurses that you are on antiplatelet medicines especially if they ask you to take new medicines.

5. Before you have dental work or surgery, ask your dentist or surgeon to speak with your heart doctor about whether or not you should stop taking your antiplatelet medicines. You may be able to stay on your aspirin, even if you need to stop Plavix® or Effient®.

Other oral antiplatelet medicines:• Pletal® (cilostazol) - Generally used by

people with blocked arteries in their legs.• Persantine® (dipyridamole) and aspirin

are often taken together prevent a stroke. • Other antiplatelet medicines such as

Ticlid® (ticlopidine) are also available.

1,550,000PCNA materials have been distributedto patients to date.

over

7

ChiCAGo, iL // ApRiL 15-17, 2010 Designed to blend the latest advancements in science with practical clinical approaches to patient management, PCNA’s 2010 Annual Symposium featured keynote addresses, lectures and workshops presented by world renowned authorities in cardiovascular risk reduction and disease management. This year’s event attracted over 600 attendees, most who serve as cardiovascular specialists across the United States, Canada and around the globe.

2010 SyMpoSiuM hiGhLiGhtS

• Cardiovascular Disease Management in the Patient with Complex Comorbidities•MovingtheGoalpostsforPrediabetesTreatment•ThisisNotYourFather’sCardiacRehab:NewModelsforNewTimes•NavigatingtheVulnerableGap:HazardsofHospitalDischarge•Conductorcise:ASOUNDWorkoutforBodyandSoul• Delivering Straightforward Nutritional Advice in Brief Clinical Encounters

SyMpoSiuMnational annual

The map at left shows attendance from the states highlighted red.

Healthcareprofessionalsfrom the following international countriesalsoattended:

The Netherlands, South Africa, Canada, Chile

2010 AnnuAL SyMpoSiuM SChoLARShipS AnD pRoGRAMSThrough the generous support of our sponsors, we have been able to allocate $10,000 to scholarships per year, which allows many of our members the opportunity to attend the PCNA Annual Symposium. In addition, educational grants from our supporters make it possible for us to provide the highest quality educational programs with expert speakers, free meals, and a reduced registration rate. Without this support, registration fees would be prohibitively high and limit the ability of nurses to attend.

8

pCnA AwARDSThefollowingPCNAannualawardswererecognizedatthisyear’sAnnualSymposium:

teRRy thoMAS CLiniCAL pRACtiCe AwARDThis award recognizes and encourages excellence in clinical practice of cardiovascular prevention by nurses. The winner is recognized at the opening of the PCNA Annual Symposium with a plaque and $1,000. The winner also receives complimentary registration, paid travel expenses, and 3-night hotel stay to attend the Symposium.

pCnA FeLLowShipFellowship provides a means to recognize and award excellence in leadership and volunteer service to PCNA. PCNA Fellows are entitled to use the designation of Fellow of PCNA (FPCNA).

exCeLLenCe in CLiniCAL pRACtiCe AwARDSponsoredbyPCNAandtheAmericanHeartAssociation’s(AHA)CouncilonCardiovascularNursing, this award recognizes and encourages excellence in cardiovascular nursing clinical practice. The winner is recognized at the annual dinner of the Council on Cardiovascular NursingheldduringtheAHAScientificSessions.

American Heart Association Scientific Councils: - Council on Cardiovascular Nursing

- Council on Clinical Cardiology

- Council on Epidemiology and Prevention

- Council on Nutrition, Physical Activity and Metabolism

Abbott LaboratoriesAstraZeneca PharmaceuticalsBoehringer IngelheimCardioDxConAgra FoodsDaiichi Sankyo, Inc. and Lilly USA, LLCGilead Sciences, Inc.General Mills, Inc., Cheerios

Inverness Medical InnovationsJournal of Cardiovascular NursingMerck & Co., Inc.Pfizer, Inc.Solvay Pharmaceuticals, Inc.St. Jude Medical, Inc.Unilever

2010 AnnuAL SyMpoSiuM SuppoRteRS

$10,000

689

allocated to scholarships that allow PCNA members to attend the Annual Symposium

cardiovascular specialists attended the 2010 Annual Symposium

“This was the most comprehensive and professionally stimulating conference of my 34-year nursing career.”

DonnA ivey, Rn // Inman, SC

“The information I gathered at this PCNA Annual Symposium will have a profound impact on my academic and nursing practice in regards to redirecting/restructuring teaching strategies on the prevention of heart disease.”

iRMA AnChetA, phD, Rn, FpCnA // Jacksonville,FL

pRoMote pRoFeSSionAL CeRtiFiCAtion AnD DeveLopMent

9

750

ChApteR pRoGRAMS

regional

PCNA programs bridge the gap between science and clinical practice. Our strong network of regional chapters across the country make it possible to offer health care providers a wide variety of live programs, networking and professional support.

PCNA’s largest network of live continuing education programs is the 2010PCNAFallLectureSeries.In2010, nearly 300 nurses, advanced practice nurses and other providers gathered in 9 cities across the country forthe2010FallLectureSeries.Another 450 streamed the sessions live via the internet.

ReGionAL ChApteRS

PacificNorthwestChapter// Seattle, WACentral Valley California Chapter // Sacramento N. California Chapter // San Francisco Bay Area Minnesota/Wisconsin Chapter // Twin Cities/DuluthChicagoland Chapter GreaterMetroDetroitChapterGreaterCincinnatiAreaChapter//Cincinnati,OHNortheast Ohio Chapter //Akron,OHMontreal/Quebec Chapter GreaterDelawareValleyChapterNortheastNewYorkChapter // Rochester MetroNewYorkChapter// NewYorkCityNorthern New Jersey Chapter // MorristownCentral Virginia Chapter // Charlottesville North Carolina Chapter // AshevilleAtlanta ChapterCentral Florida Chapter // TampaFirst Coast Chapter //Jacksonville,FLRocky Mountain Region Chapter // Denver, CO

nurses, advanced nurse specialists and other health care providers attended live or tuned in to live regional chapter programs

2010PCNARegionalChapterLeaders

10

pRoMote pRoFeSSionAL CeRtiFiCAtion AnD DeveLopMent

CouRSeSscientific online

PCNA offers many online courses that allow health care professionals to obtain contact hours of CE through AANP. Most courses are offered free of charge via the PCNA website. Coursesareavailableonthefollowingtopics:

AnGinA/StAbLe iSCheMiC heARt DiSeASe•NEW!StableIschemicHeartDisease:MaximizingQualityofLife•LatestAdvancesintheTreatmentofAngina

behAvioR MoDiFiCAtion•Mindset:ANewStrategyforHealthBehaviorChange•NEW!MotivationalInterviewinginAction:Skills&ToolstoEnhanceChangein

Physical Activity Behavior

epiDeMioLoGy•TranslatingEpidemiologyintoSoundPublicHealthAdvice

pCnA exCeLLenCe in nuRSinG LeADeRShip SeRieS•Part1:WritingStrongAbstractsforProfessionalConferences•NEW!Part2:Posters,Podiums,andPublishing:SharingYourWork

venouS thRoMboeMboLiSM• Increasing Awareness and Improving Management of Venous Thromboembolism Through theApplicationofAcceptedEvidence-BasedGuidelines

AntiCoAGuLAtion MAnAGeMent•SafeManagementofOralAnticoagulation:TheImportanceofthePatientasPartner

exeRCiSe•MoveIt!UpdateFromtheActivitySideoftheEnergyBalanceEquation•NEW!ExerciseisMedicine:UnderstandingtheEvidence•NEW!ExerciseisMedicine:PracticalExamplestoHelpGetYourPatientsMoving!

nutRition•HealthBenefitsofOmega–3FattyAcidsandWalnuts

tRiGLyCeRiDeS & hDL

•Assessment,Treatment,andEvaluationofthePatientwithElevatedTriglyceridesandLowHDL

LipiDS•LipidsOnline:VirtualLipidPreceptorshipProgram

heARt FAiLuRe•InitialEvaluationandOngoingAssessmentofthePatientwithChronicHeartFailure:Focus

on the Outpatient Setting

woMen’S heALth•TakingWomen’sHealthtoHeart:AnUpdateonWomen&CardiometabolicSyndrome•CaringforaWoman’sHeart:SettingtheStage

11

ReAChinternational

PCNAisaproudmemberoftheWorldHeartFederationandcontinuestotakeitsmissionaround the world in an effort to support and expand the role of nursing in cardiovascular disease prevention.

Cardiovasculardiseasecontinuestobethemajorcauseofdeathworldwide.Globally,nurses(and nursing organizations) are a central and essential component of research, practice, policy, and advocacy initiatives designed to promote CVD prevention. Internationally, individual nurses and nursing organizations have made unique contributions to CVD prevention, including development and implementation of innovative case management models for primary and secondary prevention of CVD.

Endorsed and supported by the Board of Directors, PCNA’s International Committee has developed a multi-component plan to identify, engage, and mobilize the international community of cardiovascular nurses in CVD prevention.

honG konG Asian Preventive Cardiology and Cardiac Rehabilitation Conference (2006, 2008 & 2010)

viñA DeL MAR, ChiLe Chilean Cardiovascular Nursing Conference (2007-2009)

MuniCh, GeRMAny European Society of Cardiology Conference (2008)

DubLin, iReLAnD Council of Cardiovascular Nursing and Allied Professionals Conference (2008 & 2009)Annual Spring Meeting on Cardiovascular Nursing (2009)

buenoS AiReS, ARGentinA World Congress of Cardiology (2008)

bARCeLonA, SpAin European Society of Cardiology Conference (2009)

new thiS yeAR!

beiJinG, ChinA World Congress of Cardiology

StoCkhoLM, SweDen European Society of Cardiology Conference

12

inCReASe pubLiC AnD poLitiCAL AwAReneSS

ADvoCACynational initiatives &

PCNA is involved in issues surrounding the public awareness of CVD prevention and the integral role that nurses play in cardiovascular risk reduction and health promotion. PCNA’s Advocacy Committee responds to legislative issues that address cardiovascular disease prevention. They also strive to increase public and political awareness of the critical role that nurses play in comprehensive cardiovascular risk reduction.

pCnA MARCheS to the hiLL to pRevent ChiLDhooD obeSity

On Tuesday, September 22, 2010, the Preventive Cardiovascular Nurses Association joined together with the Partnership for Prevention to host two caucuses entitled “Eliminating Childhood Obesity and Developing National Consensus on a Prescription for Change” in Washington, DC. Over 100 legislative representatives and individuals whose work is central to childhood obesity attended these two sessions. In addition to the caucuses hosted by PCNA and the Partnership for Prevention, the PCNA board of directors and staff met with their state Senators and Congressional Representatives to discuss the prevention of cardiovascular disease and childhood obesity. The following bills wereaddressed:ImprovingNutritionforAmerica’sChildrenAct,HEARTforWomenAct,P.A.D.Resolution, and the Johanns Amendment.

ADvoCACy pARtneRS

•AmericanHeartAssociation

• American Nurses Association

• Tobacco Free Kids

• American Diabetes Association

• American Association of Cardiovascular & Pulmonary Rehabilitation

• American College of Cardiology

• American Association of Colleges of Nursing

• Center for Science in the Public Interest

• Partnership for Prevention

nAtionAL CAMpAiGn CoLLAboRAtionS

•TheHeartTruthCampaign

• Exercise is Medicine

• National Salt Reduction Campaign

•ChronicConditionsWorkingGroup

13

FoSteR pRoDuCtive LiAiSonS

pARtneRSorganizational

PCNA is able to reach far beyond its membership to provide educational programs and materials to the members of other health care organizations. We believe that by collaborating with like-minded organizations, we can be more effective in enhancing professional recognition for cardiovascular nurses, while ultimately touching more lives and improving patient outcomes worldwide.

pCnA iS pRouD to CoLLAboRAte with the FoLLowinG oRGAnizAtionS:

• American Academy of Nurse Practitioners

• American Association of Cardiovascular and Pulmonary Rehabilitation

• American Association of Critical Care Nurses

• American Association of Diabetes Educators

• The American Association of HeartFailureNurses

• American College of Cardiology

• American Diabetes Association

• American Nurses Association

• American Nurses Credentialing Center

• American Nurses Foundation

•AmericanHeartAssociation ScientificCouncils

– Council on Cardiovascular Nursing– Council on Clinical Cardiology– Council on Epidemiology & Prevention – Council on Nutrition, Physical Activity,

& Metabolism

• Association of Black Cardiologists

• Baylor College of Medicine• Council on Cardiovascular Nursing

and Allied Professions

• European Society of Cardiology

•HartfordInstituteforGeriatricNursing

•HongKongCollegeofCardiology

• Institute for Clinical Excellence Education and Research

•MendedHearts

•TheHeartTruth-NationalHeart, Lung,andBloodInstitute

•Men’sHealthNetwork•NationalLipidAssociation

•NursingKnowledgeInternational:SigmaThetaTauInternationalHonorSociety

• Nursing Organization’s Alliance

•OfficeonWomen’sHealth– DeptofHealthandHumanServices

• P.A.D. Coalition

• Partnership for Prevention• SCAI• Society for Vascular Nursing• Society of Chest Pain Centers• Stop AFib•WorldHeartFederation•WomenHeart:TheNationalCoalition forWomenwithHeartDisease

14

pRoMote the utiLizAtion AnD DiSSeMinAtion oF ReSeARCh

ReSeARCh

next?

grants &

what’s

CARDiovASCuLAR DiSeASe pRevention ReSeARCh GRAntSponsored by PCNA and the American Nurses Foundation, this $5,000 grant encourages the research and career development of nurses. Individuals whose research is focused on cardiovascular disease prevention are encouraged to apply.

CARDiovASCuLAR DiSeASe pRevention GRADuAtion AwARDTheCardiovascularDiseasePreventionGraduationAwardisforthegraduatestudent who has demonstrated a strong commitment to the prevention of cardiovascular disease through excellence in nursing practice or research. The winner of this award receives a complimentary registration to the PCNA Annual Symposium and one year free membership in PCNA.

CoMinG in 2011

•NewpatientmaterialsonHighBloodPressure,LivingGuidelinesforWomen,Atrial Fibrillation,FamilialHypercholesterolemia,cholesterolandanupdatedclinicaltools online portal on pcna.net

• New mentoring program aimed to aid in professional development for nurses and advanced nurse practitioners

•Globalcardiovasculardiseasepreventionefforts

•Livepatientandcommunityprograms

we ARe CuRRentLy SeekinG FunDinG FoR the FoLLowinG pRoJeCtS:

•InternationalNursingleadershipmeetinginNewYorkCity,NYtoassessglobalprevention and training needs

• Educational program focused on pre-diabetes for professionals and the community

• Regional chapter educational programs and community seminars

•AdditionalsessionstotheonlinePCNAExcellenceinNursingLeadershipSeries

•Updatepatienthandbook“FightAgainstHeartFailure”

• Interactive video and web learning module focused on behavioral change and medication adherence

•UpdatetotheNationalGuidelinesandToolsforCardiovascularRiskReduction: APocketGuide

15

QueStionS? ContACt:Sue Koob, MPA ChiefExecutiveOfficer Preventive Cardiovascular Nurses Association 613 Williamson Street, Suite 200 Madison, WI 53703 Phone:608-250-2440•Fax:608-250-2410 Email:[email protected]

Follow Us on Twitter @HeartNurses

Like Our Page Facebook.com/HeartNurses


WilliamL.Haskell,PhDStanford University

MarthaN.Hill,RN,PhD,FAANJohnsHopkinsSchoolofNursing

Ronald M. Krauss, MDLawrenceBerkeleyNat’lLaboratory

Nanette K. Wenger, MDEmory University School of Medicine

Penny Kris-Etherton, PhD, RDPennsylvania State University

Sidney C. Smith, Jr., MDUNC School of Medicine

Diane M. Canova, JDPartnership for Prevention

pLAtinuM LeveLAstraZeneca PharmaceuticalsGileadSciences,Inc.Merck & Co., Inc.

GoLD LeveLDaiichi Sankyo, Inc. and LillyUSA,LLCInverness Medical Innovations

SiLveR LeveLBoehringer IngleheimBristol-Myers Squibb/ Pharmaceuticals, Inc.Forest PharmaceuticalsNovartis Pharmaceuticals CorporationThe Coca-Cola Company

bRonze LeveLCardioDx diaDexus, Inc.GeneralMills,Inc.,CheeriosConAgra FoodsUnilever

SCientiFiC ADviSoRy boARD SuppoRteRS

Jerilyn Allen, RN, ScD, FPCNA , FAAN President JohnsHopkinsUniversity,SchoolofNursing

JoyceRoss,MSN,CRNP,CS,CLS,FPCNA President-Elect Diplomate,ACCL

JaneNelsonWorel,RN,MS,APNP,FAHA,FPCNA Immediate Past President Meriter Medical Clinic

Kathy Berra, MSN, ANP-BC, FPCNA, FAAN Treasurer Stanford Prevention Research Center

JoannaSikkema,MSN,ANP-BC,FAHA,FPCNA Corporate Development Chair University of Miami, School of Nursing

MaryAnnChampagne,MSN,CNS,FAHA,FPCNA Project Review Committee Chair Stanford University Medical Center

LolaCoke,PhD,APRN-BC,CNS,FAHA,FPCNA Member-At-Large Rush University College of Nursing

LynneT.Braun,PhD,CNP,CLS,FAHA,FPCNA,FAAN Board Member Rush University Medical Center

BarbaraJ.Fletcher,RN,MN,FAHA,FPCNA,FAAN Board Member University of North Florida

LauraL.Hayman,PhD,RN,FPCNA,FAAN Board Member University of Massachusetts, Boston

SuzanneHughes,RN,MSN,FAHA,FPCNA Board Member SummaHealthSystem

CindyLamendola,MSN,ANP-BC,FAHA,FPCNA Board Member Stanford University School of Medicine

JanetB.Long,MSN,ACNP,CLS,FAHA,FPCNA Board Member Rhode Island Cardiology Center

CarolMason,ARNP,CLS,FAHA,FPCNA Board Member Diplomate,ACCL

NancyHoustonMiller,RN,BSN,FAHA,FPCNA Board Member Stanford Cardiac Rehabilitation Program

2010 boARD oF DiReCtoRS

pcna 2010 impact report

Documents